Which one is better for diagnosing cervical cancer, TCT or HPV?

Clinically, TCT and HPV tests are commonly used methods for screening cervical cancer and its precursor lesions, but they cannot help diagnose cervical cancer. It is recommended to go to a regular hospital and undergo relevant examinations and diagnoses under the guidance of a doctor.

TCT is a cytological test that collects cervical cell samples and then analyzes the morphology and structure of these cells in the laboratory. The purpose is to detect whether there are abnormalities in cervical cells, such as atypical hyperplasia, precancerous lesions, or cervical cancer. TCT examination can help detect abnormal changes in cervical cells at an early stage, so that timely treatment can be carried out to prevent the disease from progressing to cervical cancer. HPV testing is to detect whether there is human papillomavirus DNA in cervical cells. HPV is a common sexually transmitted virus, and certain high-risk HPV types are directly related to the occurrence of cervical cancer. HPV testing can identify those types of HPV that may increase the risk of cervical cancer.

TCT or HPV testing alone is usually not enough to confirm cervical cancer. Both tests are screening tools used to find possible problems. If the TCT test shows abnormal cells or the HPV test result is positive for high-risk HPV, further testing, such as a cervical biopsy, is usually needed to confirm cervical cancer.

TCT and HPV examinations are both important means of cervical cancer screening. If the test results are abnormal, you must pay attention to it and cooperate with the doctor for treatment.